COVID-19 Innovations Trigger a Molecular Revolution
The worldwide impact of COVID-19 is staggering, but it may also put us at the starting point of a revolution in the field of molecular diagnostics.
Taiwan Advanced Nanotech Inc. (TANBead) has announced that the company will exhibit its wide range of nucleic acid extraction solutions and intelligently engineered designs to the global industry experts and researchers at 2021’s AACC Annual Scientific Meeting & Clinical Lab Expo (September 26-30), AACC Location: Georgia World Congress Center, Hall C1, Booth #3041
The global healthcare industry is increasingly reliant on molecular diagnostics as a means of identifying and treating diseases like Covid-19. In the fields of genetic testing, oncology, and infectious diseases, molecular diagnostics have become an indispensable part of diagnosing and developing treatments related to health issues. Speeding up the RT-PCR sample preparation, TANBead has rolled out its product line “Maelstrom” designed to meet the demand for automated, scalable throughput extraction devices for RNA/DNA purification.
Over the last year, we have witnessed an exponential growth of testing capacity and repurposing PCR machines to the market. One of the prominent factors of the growth in molecular diagnostics is the rapid advent of testing to detect certain infectious diseases, such as SARS-CoV-2 variants. For example, polymerase chain reaction (PCR) and next-generation sequencing (NGS) have improved to the point that these techniques were used both clinically and commercially during a global pandemic.
In order to meet the increasing demand of numerous hospitals and clinical researchers from over 70 countries, TANBead has produced a modular solution for use with their existing line of Maelstrom devices. With the patented technology which can improve the mixing efficiency of magnetic beads and increase the processing sample volume, Maelstrom 9600(M9600) has become one of the most competitive automated DNA/RNA extraction instruments. M9600 can process up to 96 samples per run, which is considered high throughput. Combining TANBead prefilled extraction reagents, the system is fully validated by many medical institutions and clinical organizations.
TANBead brings together a product line that offers scalable throughput and a variety of sample types. The company also works closely with partners to develop customized reagent kits and produce potent extraction solutions, such as Eurofins, Novatec Immundiagnostica GmbH, and MESLO Ltd. TANBead provides automated extraction instruments and reagents with excellent performance and quality, which can contribute to COVID-19 detection, surveillance, and epidemic control in a post-pandemic world.
ABOUT THE COMPANY
TANBead is an innovative solution provider for nucleic acid extraction. With expertise in automation, buffer optimization, and modification of magnetic beads, we focus on offering our customers practical solutions with a variety of throughputs. We offer a wide range of products to meet the unique requirements of our customers. For more information please visit www.tanbead.com
Public Relations Supervisor